Search

everythinglearnresearchcommunity

for

Search:↓

Topical minoxidil is effective and safe for hair regrowth in Middle Eastern men with early baldness, with better results in younger patients and certain types of baldness.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Botulinum toxin-A may increase hair growth and reduce hair loss in men with baldness, and injecting near blood vessels can improve pain relief and last longer.

Botulinum toxin-A injections in the scalp can reduce hair loss and promote new hair growth in men with certain types of baldness.

Botulinum toxin injections can reduce hair loss and stimulate new hair growth in some men with male pattern baldness.

FPHL affects hair density and diameter, causing visible hair loss in older women.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

AGA more common in men, Koreans have lower rates and unique patterns.

Hair loss severity relates to increased miniaturization in female pattern hair loss.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Aromatase gene variation may increase female hair loss risk.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Finasteride can slow hair loss and promote growth in postmenopausal women.

Trichoscopy is better than trichogram for diagnosing female hair loss.

Topical minoxidil effectively treats male pattern baldness and prevents hair loss.

Herbs can potentially treat hair loss by inhibiting a key enzyme and promoting hair growth, and deficiencies in zinc, biotin, and iron are linked to hair loss.

Melatonin solution helps treat hair loss in men and women.

Finasteride shows promise for female hair loss, but more research needed.

Hair loss in women not always linked to increased oil production; other factors may be involved.

WAA-QOL measures impact of hair loss on women's well-being.

Women with female pattern hair loss often underestimate how severe it is.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Smoking and drinking worsened hair loss in men with genetic hair loss, while eating and sleeping habits didn't; genetics played a bigger role than environment in hair loss.

Fiber implantation for baldness is not recommended because it causes many problems and doesn't work well.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

AGA increased yearly, type I most common, and family history and seborrheic dermatitis often linked.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.